| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 275,242 | 729 |
| Increase/(decrease) in cash, cash equivalents and restricted cash | 33,129 | -9,554 |
| Cash and cash equivalents at beginning of period | 23,022 | - |
| Cash and cash equivalents at end of period | 56,151 | - |
Dianthus Therapeutics, Inc. DE (DNTH)
Dianthus Therapeutics, Inc. DE (DNTH)